TRANSIENT CEREBRAL-DYSFUNCTION SECONDARY TO HIGH-DOSE METHOTREXATE

[1] ABELSON HT, 1978, CANCER TREAT REP, V62, P1999

[2] ABELSON HT, 1981, CANCER TREAT REP, V65, P137

[3] Allen J, 1983, J Neurooncol, V1, P39

[4] TRANSIENT CEREBRAL-DYSFUNCTION FOLLOWING CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA [J]. ANNALS OF NEUROLOGY, 1978, 3 (05) : 441 - 444

[5] ALLEN JC, 1980, CANCER TREAT REP, V64, P1261

[6] NEUROTOXICITY AND ELEVATED CEREBROSPINAL-FLUID METHOTREXATE CONCENTRATION IN MENINGEAL LEUKEMIA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (15) : 770 - 773

[7] BLEYER WA, 1977, CANCER TREAT REP, V61, P1419

[8] LEUKOENCEPHALOPATHY IN CHILDHOOD LEUKEMIA [J]. NEUROLOGY, 1977, 27 (07) : 609 - 613

[9] DJERASSI I, 1977, CANCER TREAT REP, V61, P691

[10] DUCH DS, 1985, P AM ASSOC CANC RES, V26, P235

[1] ABELSON HT, 1978, CANCER TREAT REP, V62, P1999

[2] ABELSON HT, 1981, CANCER TREAT REP, V65, P137

[3] Allen J, 1983, J Neurooncol, V1, P39

[4] TRANSIENT CEREBRAL-DYSFUNCTION FOLLOWING CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA [J]. ANNALS OF NEUROLOGY, 1978, 3 (05) : 441 - 444

[5] ALLEN JC, 1980, CANCER TREAT REP, V64, P1261

[6] NEUROTOXICITY AND ELEVATED CEREBROSPINAL-FLUID METHOTREXATE CONCENTRATION IN MENINGEAL LEUKEMIA [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (15) : 770 - 773

[7] BLEYER WA, 1977, CANCER TREAT REP, V61, P1419

[8] LEUKOENCEPHALOPATHY IN CHILDHOOD LEUKEMIA [J]. NEUROLOGY, 1977, 27 (07) : 609 - 613

[9] DJERASSI I, 1977, CANCER TREAT REP, V61, P691

[10] DUCH DS, 1985, P AM ASSOC CANC RES, V26, P235